3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Non-Hodgkin
2
Lymphoma, Mantle-Cell
2
Lymphoma, Follicular
2
Hodgkin Disease
2
Burkitt Lymphoma
2
Uveal Melanoma
1
Recurrence
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmablastic Lymphoma
1
Oligodendroglioma
1
Neoplasms
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma
1
HIV Infections
1
Glioblastoma
1
Astrocytoma
1
Interventions
Radiosurgery
11
Temozolomide
5
Magnetic Resonance Spectroscopy
5
Specimen Handling
4
Nivolumab
4
Mental Status and Dementia Tests
4
Receptors, Interleukin-8B
3
Memantine
3
Ipilimumab
3
trastuzumab deruxtecan
2
pembrolizumab
2
Surveys and Questionnaires
2
sotorasib
1
sapanisertib
1
sacituzumab govitecan
1
pertuzumab
1
patritumab deruxtecan
1
nabiximols
1
fluciclovine F-18
1
entrectinib
1
dexamethasone acetate
1
dexamethasone 21-phosphate
1
brodalumab
1
auricularum
1
abemaciclib
1
Watchful Waiting
1
Vorinostat
1
Vitamin B 6
1
Valacyclovir
1
Trastuzumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Brain Neoplasms
×
Carmustine
×
30 days
×
Clear all
No trials found.